INS and type 2 diabetes mellitus: The fact that 13-a-OH lupanine and 17-oxo-lupanine stimulate insulin secretion only at high glucose concentrations indicates that it would reduce the risk of hypoglycemia which could be of additional value when considering their potential use in the treatment of type 2 diabetes (106).